Novavax Pins COVID-19 Hopes On Ex-US, Booster Markets
Delay In FDA Filing Until Q4
The company is planning to file with regulators in the UK, EU, Canada, Australia and New Zealand, with an emphasis on booster shots in developed markets.
The company is planning to file with regulators in the UK, EU, Canada, Australia and New Zealand, with an emphasis on booster shots in developed markets.